Elekta AB EKTAY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Elekta AB EKTAY Company Overview 

Stock Message Board http://investorshangout.com/search?q=EKTAY&am...mp;yt1=Go!

Elekta AB EKTAY Current Price and Quotes
Last Price 16.17
Previous Close 16.29 Open 16.26
Daily Range 16.28 - 16.10 52wk Range 17.74 - 13.15
Volume 7,999 Dividend 0.7036
Average Vol (3m) 12,152 Yield 4.3513
Elekta AB EKTAY

Company Verified Profile
Company Information

Birger Jarlsgatan 53
Box 7593
Stockholm SE-103 93
Sweden

Website: http://www.elekta.com
Phone: +46 8 587 254 00
Email: info@elekta.com

Elekta AB EKTAY
The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta AB EKTAY
Financial Reportings and Disclosures

Reporting Status International Reporting: OMX Nordic Exchange Stockholm
CIK 0001451160
Fiscal Year End 4/30
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification
Incorporated In: Sweden
Year of Inc. Not Available
Employees 3336 a/o Apr 30, 2013
Company Officers/Contacts

Tomas Puusepp CEO, President
Johan Sedihn COO
Hakan Bergstrom CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Elekta AB EKTAY
EKTAY Security Details Other Company Securities

Share Structure

Market Value1 $5,959,571,541 a/o Sep 27, 2013
Shares Outstanding 368,557,300 a/o Dec 31, 2012
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.22459) Sep 04, 2013 Sep 06, 2013 Sep 26, 2013
Dividend (0.23056) Sep 04, 2013 Sep 06, 2013 Sep 26, 2013
Dividend (0.47904) Sep 05, 2012 Sep 07, 2012 Sep 27, 2012
Security Notes

Capital Change=shs increased by 4 for 1 split. Ex-date=09/25/2012. Rec date=09/14/2012. Pay date=09/24/2012.
Non US Stock Exchange Listing

EKTAB - OMX Nordic Exchange Stockholm - Qualified
Short Selling Data

Short Interest 3,365 (-60.28%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon
Citi

Elekta AB EKTAY Recent News

Sept 23, 2013 Elekta Opens Global Education Center for Oncology and Neuroscience Professionals
Sept 21, 2013 Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer
Sept 21, 2013 Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System
Sept 19, 2013 New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
Sept 13, 2013 Switzerland's Hopital Riviera Improves Confidence in Patient Treatment with Elekta's Identify Solution
Sept 12, 2013 Elekta to Spotlight Versa HD System at 2013 ASTRO Annual Meeting
Sept 11, 2013 Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
Aug 28, 2013 First-ever Gamma Knife in Alaska Offers New Options for Treating Brain Cancer and Other Disorders
Aug 23, 2013 American Brachytherapy Society Receives $160,000 Grant from Nucletron, an Elekta Company, to Fund Brachytherapy Physician and Physics Residency Program
Aug 21, 2013 Elekta's Versa HD System Now Features Automated Breath Hold Gating for Improved Breast and Lung Radiotherapy

1
2
next >

Elekta AB EKTAY Financials
EKTAY


EKTAY Elekta AB Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EKTAY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EKTAY/quote
Stock Chart http://www.otcmarkets.com/stock/EKTAY/chart
Company Info http://www.otcmarkets.com/stock/EKTAY/company-info
Recent News http://www.otcmarkets.com/stock/EKTAY/news
Financials http://www.otcmarkets.com/stock/EKTAY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EKTAY/filings
Short Sales http://www.otcmarkets.com/stock/EKTAY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EKTAY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EKTAY/research
Summary http://finance.yahoo.com/q?s=EKTAY
Historical Prices http://finance.yahoo.com/q/hp?s=EKTAY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EKTAY
Basic Chart http://finance.yahoo.com/q/bc?s=EKTAY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EKTAY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EKTAY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EKTAY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EKTAY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EKTAY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EKTAY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EKTAY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EKTAY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EKTAY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EKTAY
Balance Sheet http://finance.yahoo.com/q/bs?s=EKTAY
Cash Flow http://finance.yahoo.com/q/cf?s=EKTAY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EKTAY
Market Watch http://www.marketwatch.com/investing/stock/EKTAY
Bloomberg http://www.bloomberg.com/quote/EKTAY:US
Morningstar http://quotes.morningstar.com/stock/s?t=EKTAY
Bussinessweek http://investing.businessweek.com/research/st...cker=EKTAY
Barchart http://www.barchart.com/quotes/stocks/EKTAY
OTC Short Report http://otcshortreport.com/index.php?index=EKTAY
Investopedia http://www.investopedia.com/markets/stocks/EKTAY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Executive Stock Sale Sparks Investor Interest

Updated Category News Views 53

Stock Sale by ANI Pharmaceuticals Executive ANI Pharmaceuticals Inc. (NASDAQ: ANIP) has recently gained attention due to a notable stock transaction involving one of its high-ranking officials. Meredith Cook, who serves as the Senior Vice President, General Counsel, and Secretary at the company, sold 250 shares of common stock. This sale, which amounted to about $14,205,...

Continue Reading
Welcoming Dr. Morales: A New Era for NewHydrogen's Innovation

Updated Category News Views 174

Welcoming Dr. Austin Morales to NewHydrogen Dr. Morales brings expertise in dynamic reactor operation and advanced catalytic processes. NewHydrogen, Inc. (OTCQB: NEWH), a pioneer in clean hydrogen technologies, is thrilled to announce Dr. Austin Morales’ addition to its talented UCSB Technology Team. With his extensive background in catalytic processes and reactor...

Continue Reading
42com Expands its Telecom Services in Italy with New Offerings

Updated Category News Views 111

42com Launches New ISP and Satellite Infrastructure Services 42com has dramatically expanded its service portfolio with the acquisition of assets from Milano Teleport Srl. This move has enabled the company to introduce valuable new services, including 24/7 Network Operations Center (NOC) support for LEO, VSAT, 5G, and IoT technologies. Establishing a Strong Presence in...

Continue Reading
AI Professionals Face Major Gaps in Tools and Confidence

Updated Category News Views 85

Understanding the Current Landscape of AI Professionals A recent survey unveiled concerning insights into the AI landscape, revealing that a mere 34% of AI professionals feel fully prepared to tackle the challenges associated with their organizations' AI objectives. This stark finding indicates a growing tension between AI investments and actual readiness within companies...

Continue Reading
Brazil's Meal Vouchers Market Poised for Growth with AI Insights

Updated Category News Views 513

Brazil's Meal Vouchers Market Poised for Growth The market for meal vouchers and employee benefit solutions in Brazil is projected to experience remarkable growth, with estimates indicating an increase of USD 9.96 billion from 2025 to 2029. This growth is largely fueled by the advantages offered by tax benefits and AI-driven innovations. As organizations search for ways...

Continue Reading